Onglyza Lawsuits - Lawyers Handling Onglyza Heart Failure Lawsuits Offer No-Cost, No-Obligation Onglyza Case Review
Information about Onglyza Heart Attack from National Onglyza Lawyers
Onglyza (saxagliptin), a popular drug used to regulate blood glucose levels in patients with Type II diabetes, has been linked to an increased risk for heart failure, heart attack and heart disease. Based on research showing patients taking Onglyza are hospitalized for heart failure more often than diabetics not taking Onglyza, the FDA added an Onglyza heart failure warning to the product’s label in April of 2016.
Cardiac risks such as heart disease, heart attack and heart failure from Onglyza were the subject of an FDA Endocrinologic and Metabolic Drugs Advisory Committee meeting in 2015. Onglyza was first approved for use in the United States in 2009. Believing it to be safe, patients who have taken the drug since 2009 have been exposed to an increased risk for heart failure from Onglyza at no fault of their own.
Unaware of the potential for cardiovascular problems such as heart attack or heart failure from Onglyza, doctors and patients have come to favor the drug for its effectiveness in regulating blood glucose levels and because it does not result in weight gain (a typical side effect of other glucose regulators). Marketed by the British-Swedish pharmaceutical company AstraZeneca, Onglyza sales garnered $786 million in 2015. Prior to the announcement of the April 2016 FDA Onglyza heart failure warning, the drug had been projected to yield annual sales of $2.47 billion by 2018. AstraZeneca has been aware of the connection between Onglyza and heart problems since 2013 but did not warn consumers of the potential danger until required to do so by the FDA in 2016.
If you or a loved one has suffered from heart failure, heart attack, or heart disease, you may be eligible to receive compensation through filing an Onglyza lawsuit. Attorneys handling Onglyza heart attack lawsuits provide free, no-obligation Onglyza case review to individuals and family members of persons who match this description. These Onglyza attorneys are leaders in the realm of pharmaceutical and product liability litigation, holding large corporations accountable for the harm dangerous drugs have exacted against innocent consumers.